Address: 870 Badger Circle, Grafton, WI 53024
Year founded: 1997
Product or service offered: Cedarburg Hauser Pharmaceuticals develops and manufactures complex, small-molecule active pharmaceutical ingredients for both new drug candidates and generic pharmaceuticals. These molecules fall under A categories including controlled substances and potent compounds.
Projected 2012 revenue: Not disclosed
CEO: Tony Laughrey
Target clientele: Cedarburg Hauser Pharmaceuticals works with pharmaceutical and biotech firms ranging from virtual companies to global pharmaceutical giants to meet their small molecule API needs.
Business organization memberships: Society of Chemical Manufacturers and Affiliates, Drug, Chemical & Associated Technologies Association.
What has fueled your company’s growth? “Cedarburg Hauser Pharmaceutical’s growth has been fueled by a talented and experienced group of employees and a customer-centric business approach that has led to a high percentage of repeat business.”
What is the biggest obstacle to your company’s growth? “We compete in a very large, embryonic market that is estimated to approach $67 billion dollars a year in drug development and manufacturing. Our challenge is to become a strong competitor in this immense field.”
Do you plan any changes in your company in the upcoming months? “Cedarburg Hauser Pharmaceuticals is well positioned for future growth. We are continually developing plans for capital expenditures.”
What is the outlook for the business conditions of your industry over the next several months? “The pharmaceutical industry is turning to contract development and manufacturing organizations in increasing numbers as a way to control drug development costs. We expect this trend to continue, so the industry outlook is very positive.”
What is your company’s key strategy for rising out of the recession? “Over the years, Cedarburg Hauser Pharmaceuticals has developed strong relationships with both potential and existing customers. These relationships have resulted in a pipeline of projects that help to ensure current and future revenues.”